InGeneron's Transpose® Ultra System is for investigational use only in the US. By Clicking 'Continue' I confirm acknowledgment


For Patients

Page Header Image

InGeneron is presently conducting a number of clinical trials as part of the Food and Drug Administration’s (FDA) regulatory requirement for our therapy to be approved for use in the U.S.